MGNX
MGNX
NASDAQ · Biotechnology

Macrogenics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.81
+0.11 (+6.47%)
As of Feb 8, 2:10 PM ET ·
Analyst Consensus
Hold
13
Analysts
Moderate
Coverage
Buy 7 54%
Hold 6 46%
Sell 0 0%
Price Target
Analyst Price Target +2,322.7% upside
Low Target $27.62
Average Target $43.85
High Target $64.74
Current Price $1.81
Current
$1.81
Target
$43.85
$27.62 $43.85 avg $64.74
Scenario Analysis
Bear Case
$27.62
1,426.0%
Low target
Base Case
$43.85
+2,322.7%
Avg target
Bull Case
$64.74
+3,476.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$48.45
-96.3% from high
52-Week Low
$29.26
+-93.8% from low
Target vs 52W High
$43.85
-9.5% vs high
Next Earnings Report
Feb 19, 2026 · After Market Close
3d
until earnings
EPS Est: $-0.30
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%